Muthukumarasamy Raja/LinkedIn
Aug 13, 2026, 18:31
Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
Muthukumarasamy Raja, Managing Director at GeniusArena Software B.V., shared a post on LinkedIn:
“Plasma is essential in severe bleeding because it replaces lost blood volume and provides clotting factors that help stop hemorrhage.
Yet, traditional plasma was difficult to use in emergencies because it required freezing, lengthy thawing, and strict cold-chain storage.
The FDA’s 2026 approval of EZPLAZ freeze-dried plasma represents a real breakthrough in emergency care by making plasma rapidly available where and when it is needed most.
Join JobsReach Healthcare, the healthcare industry network, to join the conversation, share your knowledge, and discover healthcare insights and opportunities.”
Stay updated with Hemostasis Today.
-
Nov 15, 2026, 15:25Hussnain Javaid: Thalassaemia 2026 New Therapies Transforming UK Practice
-
Nov 15, 2026, 15:03Francesco Antonio Veneziano: Rethinking Coronary Artery Disease Through Precision Cardiology
-
Nov 15, 2026, 14:37Denise Rezende: 100 Years of von Willebrand Disease and Advances in Diagnosis
-
Nov 15, 2026, 14:22Ahmed Alotaibi: Does Donor Sex Influence Platelet Storage Quality
-
Nov 15, 2026, 14:09Stephen Alerhand: Acute Pulmonary Embolism vs Chronic Pulmonary Hypertension
-
Nov 15, 2026, 10:32Ibrahim Gwarzo: Identifying Care Gaps and Emergency Pain Delays in Sickle Cell Disease at APHA 2026
-
Nov 15, 2026, 10:17Ify Osunkwo: How the Sickle Cell Community Can Influence FDA Drug Development Priorities
-
Nov 15, 2026, 10:11Ahmed Abdelsalam: Why Matching ABO and RhD Groups Does Not Guarantee Crossmatch Compatibility
-
Nov 15, 2026, 10:06Asma Khalil: New British Society for Haematology Guidance on Paediatric and Neonatal Transfusion